Custom Clinical Decision Support, Inc (CCDS) proudly sponsors CustomID®
CustomID bridges a major information gap, the efficient retrieval of critical site-specific information for clinicians involved in management of infectious diseases.
CustomID®
CustomID stands out by its ability to support direct posting of content by local experts, often the antimicrobial stewards.
This step does not require approval of a third party, a significant added efficiency for a health system and care of your patients. Timely updates are instantly in view by clinicians at the point of care.
Benefits for Administrative Operations
Cost Savings
Staff efficiencies
Medications
Regulatory compliance
Improvement of the Bottom Line
Consultants can see more patients by improved efficiency.
Shortening hospital length of stay makes room for more patient admissions.
Efficiency
Local editors can immediately publish updates for display.
Content sharing allows health systems to scale.
Publications and Press
Listen to this podcast interview of Dr. Rebekah Wrenn, a stewardship pharmacist at Duke University Hospital. She is the lead author of an ICHE publication citing CustomID as part of a group effort to help clinicians do the right thing.
This ICHE publication includes the role of CustomiD in antimicrobial stewardship for a 1000-bed hospital. There was a need discovered and a solution found for impacting the duration of fluoroquinolone therapy.
Wrenn RH, Slaton CN, Diez T Sr, Turner NA, Yarrington ME, Anderson DJ, Moehring RW. The devil’s in the defaults: An interrupted time-series analysis of the impact of default duration elimination on exposure to fluoroquinolone therapy. Infect Control Hosp Epidemiol. 2024 Feb 13:1-7. doi: 10.1017/ice.2024.16. Epub ahead of print. PMID: 38347810.
Perez R, Yarrington ME, Adams MB, Deri CR, Drew RH, Smith MJ, Spivey J, Wrenn RH, Moehring RW. Pandemic hits: Evaluation of an antimicrobial stewardship program website for hospital communication during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2023 Oct;44(10):1701-1703. doi: 10.1017/ice.2023.43. Epub 2023 Apr 12. PMID: 37042608.
Emphasizing the importance of ensuring education and guidance to reach clinicians, even more so during the pandemic and we did it!
IDweek 2022 poster presentation about increased engagement with CustomID during the Covid pandemic “Pandemic Hits: Evaluation of an Antimicrobial Stewardship Program Website for Hospital Communication During the COVID-19 Pandemic” by Duke ID Fellow, Dr. Rey Perez et al. Submission ID: 1264441.
Conclusion: “Our ASP’s website was a highly utilized, practical tool for disseminating practice-changing information during the pandemic. Use increased over time and especially during surges. Though misinformation and miscommunication are challenges, an electronic reference customized for local practice and rapidly updated by ASPs offers critical support for front-line clinicians.”
GrepBeat Triangle Tech News ran a feature and video about CustomID.
Council on Entrepreneurial Development showcased CustomID during the Venture Connect summit.
Study citing the use of CustomID to monitor bacteriuria resistance patterns in pregnant women
Denoble A, Reid MHW, Krischak MM, Rosett DH, Sachdeva MS, Weaver MK, Heine RP, Dotters-Katz S. Bad bugs: Antibiotic-resistant bacteriuria in pregnancy and risk of pyelonephritis. Am J Obstet Gynecol MFM. 2021 Nov 29:100540. doi: 10.1016/j.ajogmf.2021.100540. Epub ahead of print. PMID: 34856419.
Newsletter posts highlight about CustomID from the Duke Department of Medicine: “Revolutionizing how medical guidelines can be shared, CustomID paves the way“.
Study about ED management of UTIs, improving concordance to guidelines, including CustomID as a resource, presented during IDWeek 2020.
Blum, Karen. “ABX Stewardship Spreads Its Wings,” Pharmacy Practice News
The Team
As Founder and CEO Dr. Adams is a physician leader of Custom Clinical Decision Support, Inc.
Before stepping out fulltime to launch CCDS, a spinout company from Duke University, Adams served as the Vice-Chair for Clinical Affairs in the Department of Medicine at Duke University, a position she held for six years. She also maintained a medical practice at Duke and was regularly recognized by her peers in Castle Connelly Top Doctors.
Her research emphasized the impact of emerging technologies on information management, for example, creating an enterprise-wide solution at Duke for research data security management and leading studies of mobile technology adoption and telegenetics. As a co-author, her paper on information retrieval has been cited by others in more than 2000 publications. It was on this background that she led the innovation of “CustomID”, a novel communications platform in the management infectious diseases. Upon completion of residency training in internal medicine at UNC in Chapel Hill, she was named Chief Resident of the internal medicine program.
Dr. Adams earned a master’s degree in chemistry from Mount Holyoke College where she was elected to membership in Sigma Xi, the national scientific research honor society, and she completed a bachelor’s degree with a major in chemistry from Randolph-Macon Woman’s College.
An accomplished nursing informaticist, Dr. Jenkins has served as an advisor and member of the CCDS Board of Directors since the company’s inception in 2016.
She currently directs the online graduate program in nursing informatics and teaches informatics to hundreds of Doctor of Nursing Practice students at Rutgers University School of Nursing. She is experienced in the development, use, and evaluation of electronic tools for primary care providers and consumers. As a Scientific Review Officer at the National Institutes of Health, Center for Scientific Review, she managed peer reviews of informatics research and related small business innovation research.
Dr. Jenkins has clinical experience as a Family Nurse Practitioner in five states and in Harlem in New York City. She evaluated the implementation of a patient portal in the NYC Department of Health and Mental Hygiene’s Primary Care Information Project in advance of the national rollout of electronic health records.
Dr. Jenkins earned a doctor of philosophy in nursing from the University of
Pennsylvania, followed by coursework in Health Informatics at Columbia University. She holds a master’s degree and a bachelor of science in nursing from the University of Missouri-Columbia.
Dr. Sarubbi is an advisor and member of the Board of Directors for Custom Clinical Decision Support, Inc, a position she has held since 2020. She is currently the pharmacy manager for clinical services at UNC REX Healthcare and an educator for the UNC Eshelman School of Pharmacy.
In her previous position at Duke University, a 1000-bed acute care hospital, Christina was instrumental with Dr. Adams in the design and development of CustomID. While at Duke she coordinated the infectious diseases pharmacy programs and co-directed the antimicrobial stewardship and evaluation team. Sarubbi has further early career experience as a clinical pharmacist at the University of Virginia Health System. She was the Chief Resident of her pharmacy training program at the University of California San Diego Health System.
The University of North Carolina has been Christina’s educational home, graduating first with a bachelor’s degree in chemistry, followed by a doctor of pharmacy degree from the UNC Eshelman School of Pharmacy and a master’s degree in business administration from the UNC Kenan-Flagler Business School.
Alan is a business advisor and consultant for Custom Clinical Decision Support, Inc (CCDS, Inc). His relationship to CCDS dates back to the early days of the CustomID prototype and subsequent launching from Duke University of the spinout company, CCDS, Inc.
His experience includes a venture-backed biotech start-up sold to Pfizer. He has varied executive level sales and marketing experiences with pharmaceutical companies, both Merck and SmithKline Beecham in Europe.
In 2023 Alan retired after 25 years with Duke University Medical Center as the Director of Corporate and Venture Development.
Herosian holds a master’s degree in business administration from Rutgers University and a bachelor’s degree from Tufts University.
